WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Pharma firms pile pressure on the UK as Trump's drug pricing order looms

A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.

Raccontata dacnbc.comtheguardian.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo9 mesi fa

Pharma firms pile pressure on the UK as Trump's drug pricing order looms

A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.

originale
theguardian.com9 mesi fa

Big pharma firms have paused nearly £2bn in UK investments this year

Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 15 settembre 2025·cnbc.com

    How the UK fell out with big pharma

    The U.K. is in the midst of a falling out with big pharma over drug pricing. Merck has walked away from a £1 billion facility in London and pulled its research activities…

  2. martedì 16 settembre 2025·theguardian.com

    Big pharma firms have paused nearly £2bn in UK investments this year

    Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

  • martedì 16 settembre 2025·cnbc.com

    Pharma firms pile pressure on the UK as Trump's drug pricing order looms

    A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.